IGF1 and amyotrophic lateral sclerosis: Evidence of liver inflammation and changes in IGF-1 axis together with the finding that modulating the activity of NKT cells is beneficial in mSOD1 mice, provide further support for the necessity of a proper immune response in ALS, and suggests novel secondary targets for therapeutic intervention in this disease and for other related neurodegenerative conditions.